Prominent crowdfunding platforms such as kickstarter and indiegogo are being used to promote cost-effective products effectively of which some have even over achieved their funding targets within a year. Governments across the world are supporting 3D printing technology by providing monetary stimulus for different areas. The overwhelming support seen across the world could undermine several expert opinions that have previously indicated slow growth of the market in real world scenario. SA-BRC analysis expects the healthcare 3D printing technology to grow stronger in coming years and peaking in 15 years wherein bioprinting and biofabrication rise to the fore.
United Kingdom, Sweden, Poland, Germany, Belgium and Italy are at the forefront of the European 3D printing market. The market is growing considerably within countries such as Poland as well with a large number of players in the region such as Zortrax, Zmorph and 3D Gence. There is also a stream of emerging players in other parts of Europe and particularly in Italy such as Ira3D, DWS, and ShareBot. A recent presentation of EU regulation on customized medical devices says that the manufacturers of medical devices for an individual patient, so called 'custom-made devices', must ensure that their devices are safe and perform as intended, but their regulatory burden remains low. This presents a major opportunity for new entrants in Europe as compared to United States; however, the actual real world effects of low regulations may be undermined by authorities.
The dangers of 3D printing of weapons may lead to a frenzied spur of regulatory changes in coming years since innovation and trends of 3D printing vastly outpace the regulatory considerations required for it. This threat is however limited to the manufacturing of metal or polymer components in healthcare. The 3D printing of tissue on the other hand is a different ball-game altogether. The application of 3D printing in wound care and organ regeneration includes printing of tissue and living biological material which is one of the most disruptive technologies introduced in recent years. Leading player in this area is Organovo which has been in the market for a while now. Several other notable players include BioBots, RegenHU, Cyfuse Biomedical, 3D Bioprinting Solutions, Revotek (China) and Rokit. In 2015, human trials of 3D printed bone tissue began in China by Xi'an Particle Cloud. Bioprinting of bones and skeletal tissue will require extensive imaging and surgical guides particularly for implanting spine in patients. In 2015, Revotek a company based in Chengdu, capital of southwest China's Sichuan Province, released the world's first 3D blood vessel bio-printer.
Download the full report:
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: email@example.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-healthcare-3d-printers-applications-products-services--ancillary-market-assessment--forecast-2015-2019-300378775.html